Literature DB >> 16940520

Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Stefan Kunz1, Jillian M Rojek, Amanda J Roberts, Dorian B McGavern, Michael B A Oldstone, Juan Carlos de la Torre.   

Abstract

Neonatal infection of most mouse strains with lymphocytic choriomeningitis virus (LCMV) leads to a life-long persistent infection characterized by high virus loads in the central nervous system (CNS) in the absence of inflammation and tissue destruction. These mice, however, exhibit impaired learning and memory. The occurrence of cognitive defects in the absence of overt CNS pathology led us to the hypothesis that chronic virus infection may contribute to neuronal dysfunction by altering the host's gene expression profile. To test this hypothesis, we examined the impact of LCMV persistence on host gene expression in the CNS. To model the natural route of human congenital CNS infection observed with a variety of viruses, we established a persistently infected mouse colony where the virus was maintained via vertical transmission from infected mothers to offspring (LCMV-cgPi). LCMV-cgPi mice exhibited a lifelong persistent infection involving the CNS; the infection was associated with impaired spatial-temporal learning. Despite high viral loads in neurons of the brains of adult LCMV-cgPi mice, we detected changes in the host's CNS gene expression for only 75 genes, 56 and 19 being significantly induced and reduced, respectively. The majority of the genes induced in the brain of LCMV-cgPi mice were interferon (IFN)-stimulated genes (ISGs) and included the transcription factors STAT1 and IRF9, the ISG15 protease UBP43, and the glucocorticoid attenuated-response genes GARG16 and GARG49. Based on their crucial role in antiviral defense, these ISGs may play an important role in limiting viral spread and replication. However, since IFNs have also been implicated in adverse effects on neuronal function, the chronic induction of some ISGs may also contribute to the observed cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940520      PMCID: PMC1563940          DOI: 10.1128/JVI.00795-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Dysregulation of protein modification by ISG15 results in brain cell injury.

Authors:  Kenneth J Ritchie; Michael P Malakhov; Christopher J Hetherington; Liming Zhou; Marie-Terese Little; Oxana A Malakhova; Jack C Sipe; Stuart H Orkin; Dong-Er Zhang
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

2.  Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations.

Authors:  J D Chismar; T Mondala; H S Fox; E Roberts; D Langford; E Masliah; D R Salomon; S R Head
Journal:  Biotechniques       Date:  2002-09       Impact factor: 1.993

Review 3.  The long-term potential of LTP.

Authors:  Robert C Malenka
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

Review 4.  Persistence of RNA viruses in the central nervous system.

Authors:  K Kristensson; E Norrby
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

Review 5.  The interferon antiviral response: from viral invasion to evasion.

Authors:  Nathalie Grandvaux; Benjamin R tenOever; Marc J Servant; John Hiscott
Journal:  Curr Opin Infect Dis       Date:  2002-06       Impact factor: 4.915

6.  Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains.

Authors:  F J Dutko; M B Oldstone
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

7.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses.

Authors:  S Saha; P N Rangarajan
Journal:  J Gen Virol       Date:  2003-07       Impact factor: 3.891

9.  Lymphocytic choriomeningitis virus: emerging fetal teratogen.

Authors:  Leslie L Barton; Marilyn B Mets; Cynthia L Beauchamp
Journal:  Am J Obstet Gynecol       Date:  2002-12       Impact factor: 8.661

Review 10.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

View more
  20 in total

1.  Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.

Authors:  Jillian M Rojek; Kevin P Campbell; Michael B A Oldstone; Stefan Kunz
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

2.  Neuro-invasion by a 'Trojan Horse' strategy and vasculopathy during intrauterine flavivirus infection.

Authors:  Helle Bielefeldt-Ohmann; Natalia P Smirnova; Airn-Elizabeth Tolnay; Brett T Webb; Alfredo Q Antoniazzi; Hana van Campen; Thomas R Hansen
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

3.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

4.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

5.  Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response.

Authors:  William R Wikoff; Ewa Kalisak; Sunia Trauger; Marianne Manchester; Gary Siuzdak
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

6.  Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons.

Authors:  Phi Truong; Sara Heydari; Lucile Garidou; Dorian B McGavern
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

7.  Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Sébastien Emonet; Panagiotis Giannakas; Beatrice Cubitt; Adolfo García-Sastre; Juan C de la Torre
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120.

Authors:  Ricky Maung; Melanie M Hoefer; Ana B Sanchez; Natalia E Sejbuk; Kathryn E Medders; Maya K Desai; Irene C Catalan; Cari C Dowling; Cyrus M de Rozieres; Gwenn A Garden; Rossella Russo; Amanda J Roberts; Roy Williams; Marcus Kaul
Journal:  J Immunol       Date:  2014-07-16       Impact factor: 5.422

9.  Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.

Authors:  Jillian M Rojek; Giulia Pasqual; Ana B Sanchez; Ngoc-Thao Nguyen; Juan-Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 10.  Lymphocytic choriomeningitis infection of the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Front Biosci       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.